A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis von Jindani, A., Borgulya, G., de Patiño, I. Westermann, Gonzales, T., de Fernandes, R. A., Shrestha, B., Atwine, D., Bonnet, M., Burgos, M., Dubash, F., Patel, N., Checkley, A. M., Harrison, T. S., Mitchison, D., Tuberculosis, International Consortium for Trials of Chemotherapeutic Agents in, George's, St, London, University of

Volltext